The global AI in medical imaging market size is estimated to garner USD 14,271.80 million by 2032 from USD 762.84 million in 2022, increasing with a CAGR of 33.1% according to a study by Precedence Research.
AI in medical imaging
The Asia Pacific AI in medical imaging market size was worth USD 219.64 million in 2022. It is projected to reach around USD 3,407.61 million by 2032, increasing with a CAGR of 34.20% in the forecast period.
With the use of AI in medical imaging, medical professionals are enabled to provide accurate, effective, and customized diagnosis and treatment. Doctors can accurately identify abnormalities and diagnose diseases.
The technology has increased the precision of medical diagnosis, screening results, and the capacity to predict disease. It also eliminates workload and manual labor by automating analysis and addresses the medical field talent gap by offering help in decision-making.
Some of the uses of AI in medical imaging are in the fields of digital pathology, oncology, cardiovascular, neurology, respiratory, mammography, and oral diagnostics.
Drivers and concerns
Increasing early disease detection demand, shortage of healthcare professionals, and growing adoption of AI in healthcare are driving market growth.
On the other hand, some of the factors that challenge market growth are data privacy and security concerns, lack of transparency and explainability, regulatory approval and standardization, clinical validation and acceptance, and high costs.
